Methods of treating inflammatory and autoimmune diseases with natalizumab | Patent Publication Number 20190315871
US 20190315871 A1Patent NumberUS 11292845 B2
Application Number16357179
Filled DateMar 18, 2019
Priority DateFeb 28, 2006
Publication DateOct 17, 2019
Original AssigneeBiogen
Current AssigneeBiogen Ma Inc.
Inventor/ApplicantsIvan Lieberburg
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.